Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Androgen Deprivation Therapy In Cardiovascular Disease - A Longitudinal Prostate Cancer Study (RADICAL PC1) & A Randomized Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients (RADICAL PC2)

NCT03127631 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT03127631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03127631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Androgen Deprivation Therapy In Cardiovascular Disease - A Longitudinal Prostate Cancer Study (RADICAL PC1) & A Randomized Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients (RADICAL PC2)
Lead sponsor
McMaster University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 21, 2015
Completion date
December 31, 2026
Enrollment
5,000 (estimated)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, prostate cancer